Fairchem Organics Ltd Q3 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/tt76pho4erew3phhn3sdasbg.pdf

Key Takeaways


The Paint Demand Shock

Nahoosh Jariwala: "the fall in sales has been only and only for the reason and that is the lack of demand from our customers in the paint industry and not because of we losing out on any of our customers or the paint companies replacing our products with some other products."

Margin & Cost Management

Management: "the percentage term is very difficult thing to comment on because if the prices remain at this level stable as far as raw material and finished goods are concerned, then it is okay and it actually was the case from 1996 till end of 2021 or even up to March 2022, but thereafter post this February 2022, Russia-Ukraine war, the instability in the last 12 months, the volatility in the pricing that has actually ruined this entire thing"

Strategic Diversification Away from Paint

Management: "it is our ultimate dream to one day go ahead and make mix Tocopherol's pure 100% and ultimately Vitamin E we have decided to remain in this business."

Raw Material & Competitive Dynamics

Management: "We haven't seen this type of volatility in the last 25 years of our existence. For the first time this is happening, I feel once the things stablize then there should not be anything"

Volume & Realization Outlook


Guidance & Commitments

CommitmentSpecificsTimeline
New epoxy-industry product commercializationNew raw-material-based product for epoxy industry using existing equipmentDecember 2023 or at most March 2024
Isostearic plant commissioningPlant to be commissionedApril–June quarter (Q1 FY24)
FY24 topline vs FY23FY24 topline anticipated higher than FY23FY24
FY24 bottomline vs FY23FY24 bottomline anticipated higher than FY23FY24
FY24 volume vs FY22March FY22 sales levels "for sure" recoveredFY24
Tocopherol forward-integration decisionDefer temporarily and pivot equipment to new raw material, or proceed with upgradeDecision pending; no timeline given
Long-term volume growthMaintain 10-12% average annual volume growthYears to come

Key Metrics

MetricQ3 FY23
Operational revenue₹102 cr
EBITDA₹4 cr
EBITDA margin3.51%
Net profit after tax₹0.6 cr
PAT margin0.59%
9M FY23 operational revenue₹496 cr
9M FY23 EBITDA₹53 cr, EBITDA margin 10.68%
9M FY23 net profit after tax₹32 cr, PAT margin 6.37%
Sales volume9,700 metric tons, down from 14,800 metric tons in Q2 FY23
Sales volume decline QoQ~35%
Pricing degrowth QoQ10%
Raw material process quantity8,700 tons, down from 16,700 tons in Q2 FY23
Raw material purchase volume10,400 tons
9M FY23 Dimer Acid value₹130 cr
9M FY23 Linoleic Acid value₹234 cr
Dimer Acid Indian market share~65%, balance 35% from imports
Tocopherol share of total sales5%
Combined share of Linoleic and Dimer Acid in total sales70–75%
FY23 full-year processing target54,000 to 55,000 tons, versus ~59,000 tons in FY22
Raw material price level vs pre-Feb 202210–15% higher, having peaked at nearly 2x then falling to ~1.3x